Skip to main content
Quest Diagnostics

Retrospective Analysis of >25,000 Rare Disease Patients Confirms Biallelic Variants in the NRAP Gene are a Significant Cause of Dilated Cardiomyopathy [oral presentation]

CAGC ACCG 2020: Canadian Association of Genetic Councellors Annual Education Conference
Virtual [in-person conference canceled], October 21 - 23, 2020

Retrospective Analysis of >25,000 Rare Disease Patients Confirms Biallelic Variants in the NRAP Gene are a Significant Cause of Dilated Cardiomyopathy [oral presentation]

Authors: Koskenvuo J, Saarinen I, Ahonen S, Tommiska J, Weckström S, Seppälä EH, Tuupanen S, Kangas-Kontio T, Schleit J, Heliö K, Hathaway J, Gummesson A, Dahlberg P, Ojala T, Vepsäläinen V, Kytölä V, Muona M, Sistonen J, Salmenperä P, Gentile M, Paananen J, Myllykangas S, Alastalo T-P, Heliö T

Specialties: genetics, cardiology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.